Tubidy
    Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia HD

    Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia HD

    02:10 |
    Download MP3

    Related Videos

    The PI3K/AKT signalling pathway HD 4:43

    The PI3K/AKT signalling pathway HD

    The Wnt pathway in a normal and in a tumour cell HD 3:14

    The Wnt pathway in a normal and in a tumour cell HD

    The JAK/STAT pathway 3:44

    The JAK/STAT pathway

    Oncogenic activation receptor tyrosine kinases 4:00

    Oncogenic activation receptor tyrosine kinases

    General aspects of signal transduction 5:30

    General aspects of signal transduction

    The MAP-Kinase (MAPK) signalling pathway HD 5:10

    The MAP-Kinase (MAPK) signalling pathway HD

    NF-κB pathways, Part 2: Alternative NF-κB pathway 2:55

    NF-κB pathways, Part 2: Alternative NF-κB pathway

    NF-κB pathways, Part 1: The canonical pathway of NF-κB activation 4:52

    NF-κB pathways, Part 1: The canonical pathway of NF-κB activation

    The hedgehog signaling pathway – Part 1: Normal situation 6:24

    The hedgehog signaling pathway – Part 1: Normal situation

    The metastatic thrombus HD 2:24

    The metastatic thrombus HD

    Apoptosis HD 5:06

    Apoptosis HD

    The MAP-Kinase (MAPK) signalling pathway 5:06

    The MAP-Kinase (MAPK) signalling pathway

    The cell cycle - Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors 7:47

    The cell cycle - Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

    The cell cycle, Part 1: Phases and checkpoints 5:20

    The cell cycle, Part 1: Phases and checkpoints

    The Wnt pathway in a normal and in a tumour cell 3:14

    The Wnt pathway in a normal and in a tumour cell

    The hedgehog signaling pathway – Part 2 3:38

    The hedgehog signaling pathway – Part 2

    Notch signaling 9:48

    Notch signaling

    The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 02 1:57

    The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 02

    Hypoxia Inducible Factors (HIFs), Part 2: Regulation of HIF under normoxic and hypoxic conditions 6:55

    Hypoxia Inducible Factors (HIFs), Part 2: Regulation of HIF under normoxic and hypoxic conditions

    Activation of mTORC1 in hamartoma syndromes and spontaneous tumors 4:21

    Activation of mTORC1 in hamartoma syndromes and spontaneous tumors